Some cytokines and growth factors have been reported to increase the concentration of checkpoint ligand PD-L1 on tumor cells, such as interferon-γ (IFNγ) [14], tumor necrosis factor α (TNFα) [15], or epidermal growth factor (EGF) [16]. The gene discussed is EGF; the disease is neoplasm.